Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Human Umbilical Cord Mesenchymal Stromal Cells Attenuate Systemic Sepsis in Part by Enhancing Peritoneal Macrophage Bacterial Killing via Heme Oxygenase-1 Induction in Rats.

Jerkic M, Gagnon S, Rabani R, Ward-Able T, Masterson C, Otulakowski G, Curley GF, Marshall J, Kavanagh BP, Laffey JG.

Anesthesiology. 2020 Jan;132(1):140-154. doi: 10.1097/ALN.0000000000003018.

PMID:
31764154
2.

Accuracy of pediatric cricothyroid membrane identification by digital palpation and implications for emergency front of neck access.

Fennessy P, Walsh B, Laffey JG, McCarthy KF, McCaul CL.

Paediatr Anaesth. 2019 Nov 20. doi: 10.1111/pan.13773. [Epub ahead of print]

PMID:
31746536
3.

Nebulized Mesenchymal Stem Cell Derived Conditioned Medium Retains Antibacterial Properties Against Clinical Pathogen Isolates.

McCarthy SD, Horgan E, Ali A, Masterson C, Laffey JG, MacLoughlin R, O'Toole D.

J Aerosol Med Pulm Drug Deliv. 2019 Nov 15. doi: 10.1089/jamp.2019.1542. [Epub ahead of print]

PMID:
31730399
4.

What's new in airway management of the critically ill.

Russotto V, Myatra SN, Laffey JG.

Intensive Care Med. 2019 Nov;45(11):1615-1618. doi: 10.1007/s00134-019-05757-0. Epub 2019 Sep 16. No abstract available.

PMID:
31529354
5.

Modulating the distribution and fate of exogenously delivered MSCs to enhance therapeutic potential: knowns and unknowns.

Masterson CH, Curley GF, Laffey JG.

Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):41. doi: 10.1186/s40635-019-0235-4. Review.

6.

Demographics, management and outcome of females and males with acute respiratory distress syndrome in the LUNG SAFE prospective cohort study.

McNicholas BA, Madotto F, Pham T, Rezoagli E, Masterson CH, Horie S, Bellani G, Brochard L, Laffey JG; LUNG SAFE Investigators and the ESICM Trials Group.

Eur Respir J. 2019 Oct 17;54(4). pii: 1900609. doi: 10.1183/13993003.00609-2019. Print 2019 Oct.

PMID:
31346004
7.

Overexpression of IL-10 Enhances the Efficacy of Human Umbilical-Cord-Derived Mesenchymal Stromal Cells in E. coli Pneumosepsis.

Jerkic M, Masterson C, Ormesher L, Gagnon S, Goyal S, Rabani R, Otulakowski G, Zhang H, Kavanagh BP, Laffey JG.

J Clin Med. 2019 Jun 13;8(6). pii: E847. doi: 10.3390/jcm8060847.

8.

Impact of Early Acute Kidney Injury on Management and Outcome in Patients With Acute Respiratory Distress Syndrome: A Secondary Analysis of a Multicenter Observational Study.

McNicholas BA, Rezoagli E, Pham T, Madotto F, Guiard E, Fanelli V, Bellani G, Griffin MD, Ranieri M, Laffey JG; ESICM Trials Group and the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) Investigators.

Crit Care Med. 2019 Sep;47(9):1216-1225. doi: 10.1097/CCM.0000000000003832.

PMID:
31162201
9.

The worldwide assessment of separation of patients from ventilatory assistance (WEAN SAFE) ERS Clinical Research Collaboration.

Heunks L, Bellani G, Pham T, Brochard L, Laffey JG.

Eur Respir J. 2019 Mar 18;53(3). pii: 1802228. doi: 10.1183/13993003.02228-2018. Print 2019 Mar. No abstract available.

PMID:
30886021
10.

Extracellular Vesicles from Interferon-γ-primed Human Umbilical Cord Mesenchymal Stromal Cells Reduce Escherichia coli-induced Acute Lung Injury in Rats.

Varkouhi AK, Jerkic M, Ormesher L, Gagnon S, Goyal S, Rabani R, Masterson C, Spring C, Chen PZ, Gu FX, Dos Santos CC, Curley GF, Laffey JG.

Anesthesiology. 2019 May;130(5):778-790. doi: 10.1097/ALN.0000000000002655.

PMID:
30870158
11.

Declining Mortality in Patients With Acute Respiratory Distress Syndrome: An Analysis of the Acute Respiratory Distress Syndrome Network Trials.

Zhang Z, Spieth PM, Chiumello D, Goyal H, Torres A, Laffey JG, Hong Y.

Crit Care Med. 2019 Mar;47(3):315-323. doi: 10.1097/CCM.0000000000003499.

PMID:
30779718
12.

Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study.

Pham T, Serpa Neto A, Pelosi P, Laffey JG, De Haro C, Lorente JA, Bellani G, Fan E, Brochard LJ, Pesenti A, Schultz MJ, Artigas A; LUNG SAFE Investigators* and the European Society of Intensive Care Medicine Trials Group.

Anesthesiology. 2019 Feb;130(2):263-283. doi: 10.1097/ALN.0000000000002508.

PMID:
30499850
13.

Cell therapy in acute respiratory distress syndrome.

Horie S, Gonzalez HE, Laffey JG, Masterson CH.

J Thorac Dis. 2018 Sep;10(9):5607-5620. doi: 10.21037/jtd.2018.08.28. Review.

14.

Is Activity Tracker-Measured Ambulation an Accurate and Reliable Determinant of Postoperative Quality of Recovery? A Prospective Cohort Validation Study.

Massouh F, Martin R, Chan B, Ma J, Patel V, Geary MP, Laffey JG, Wijeysundera DN, Abdallah FW.

Anesth Analg. 2019 Oct;129(4):1144-1152. doi: 10.1213/ANE.0000000000003913.

PMID:
30379677
15.

Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database.

Boyle AJ, Madotto F, Laffey JG, Bellani G, Pham T, Pesenti A, Thompson BT, O'Kane CM, Deane AM, McAuley DF; LUNG SAFE Investigators; ESICM Trials Group.

Crit Care. 2018 Oct 27;22(1):268. doi: 10.1186/s13054-018-2158-y.

16.

Recommended Reading from the Galway University Hospitals, Department of Anaesthesia and Intensive Care Medicine Fellows.

Rezoagli E, McNicholas B, Moran P, Laffey JG.

Am J Respir Crit Care Med. 2018 Oct 2. doi: 10.1164/rccm.201804-0782RR. [Epub ahead of print] No abstract available.

PMID:
30277812
17.

Human Mesenchymal Stem Cell Secretome from Bone Marrow or Adipose-Derived Tissue Sources for Treatment of Hypoxia-Induced Pulmonary Epithelial Injury.

Shologu N, Scully M, Laffey JG, O'Toole D.

Int J Mol Sci. 2018 Sep 30;19(10). pii: E2996. doi: 10.3390/ijms19102996.

18.

Sepsis: Therapeutic Potential of Immunosuppression versus Immunostimulation.

Rezoagli E, Masterson CH, McCarthy SD, Laffey JG.

Am J Respir Cell Mol Biol. 2019 Jan;60(1):128-130. doi: 10.1165/rcmb.2018-0284RO. No abstract available.

PMID:
30230345
19.

Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries.

Abe T, Madotto F, Pham T, Nagata I, Uchida M, Tamiya N, Kurahashi K, Bellani G, Laffey JG; LUNG-SAFE Investigators and the ESICM Trials Group.

Crit Care. 2018 Aug 17;22(1):195. doi: 10.1186/s13054-018-2126-6.

20.

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.

Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, McDowell C, Laffey JG, O'Kane CM, McAuley DF; Irish Critical Care Trials Group.

Lancet Respir Med. 2018 Sep;6(9):691-698. doi: 10.1016/S2213-2600(18)30177-2. Epub 2018 Aug 2.

21.

Negative trials in critical care: why most research is probably wrong.

Laffey JG, Kavanagh BP.

Lancet Respir Med. 2018 Sep;6(9):659-660. doi: 10.1016/S2213-2600(18)30279-0. Epub 2018 Jul 27. No abstract available.

PMID:
30061048
22.

A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk.

McDonnell MJ, O'Toole D, Ward C, Pearson JP, Lordan JL, De Soyza A, Loebinger M, Chalmers JD, Laffey JG, Rutherford RM.

Respir Med. 2018 Aug;141:132-143. doi: 10.1016/j.rmed.2018.06.031. Epub 2018 Jun 30. Review.

PMID:
30053958
23.

Syndecan-2-positive, Bone Marrow-derived Human Mesenchymal Stromal Cells Attenuate Bacterial-induced Acute Lung Injury and Enhance Resolution of Ventilator-induced Lung Injury in Rats.

Masterson C, Devaney J, Horie S, O'Flynn L, Deedigan L, Elliman S, Barry F, O'Brien T, O'Toole D, Laffey JG.

Anesthesiology. 2018 Sep;129(3):502-516. doi: 10.1097/ALN.0000000000002327.

PMID:
29979191
24.

Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database.

Cortegiani A, Madotto F, Gregoretti C, Bellani G, Laffey JG, Pham T, Van Haren F, Giarratano A, Antonelli M, Pesenti A, Grasselli G; LUNG SAFE Investigators and the ESICM Trials Group.

Crit Care. 2018 Jun 12;22(1):157. doi: 10.1186/s13054-018-2079-9.

25.

Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study.

Madotto F, Pham T, Bellani G, Bos LD, Simonis FD, Fan E, Artigas A, Brochard L, Schultz MJ, Laffey JG; LUNG SAFE Investigators and the ESICM Trials Group.

Intensive Care Med. 2018 May;44(5):564-577. doi: 10.1007/s00134-018-5152-6. Epub 2018 Apr 9.

PMID:
29632996
26.

Should continuous rather than single-injection interscalene block be routinely offered for major shoulder surgery? A meta-analysis of the analgesic and side-effects profiles.

Vorobeichik L, Brull R, Bowry R, Laffey JG, Abdallah FW.

Br J Anaesth. 2018 Apr;120(4):679-692. doi: 10.1016/j.bja.2017.11.104. Epub 2018 Feb 13.

27.

Mesenchymal stem cells enhance NOX2-dependent reactive oxygen species production and bacterial killing in macrophages during sepsis.

Rabani R, Volchuk A, Jerkic M, Ormesher L, Garces-Ramirez L, Canton J, Masterson C, Gagnon S, Tatham KC, Marshall J, Grinstein S, Laffey JG, Szaszi K, Curley GF.

Eur Respir J. 2018 Apr 26;51(4). pii: 1702021. doi: 10.1183/13993003.02021-2017. Print 2018 Apr.

28.

Simvastatin to reduce pulmonary dysfunction in patients with acute respiratory distress syndrome: the HARP-2 RCT.

McAuley DF, Laffey JG, O’Kane CM, Perkins GD, Mullan B, Trinder TJ, Johnston P, Hopkins PA, Johnston AJ, Murphy L, McNally C, Agus AM, McDowell C, Jackson C.

Southampton (UK): NIHR Journals Library; 2018 Jan.

29.

Research in Extracorporeal Life Support: A Call to Action.

Brodie D, Vincent JL, Brochard LJ, Combes A, Ferguson ND, Hodgson CL, Laffey JG, Mercat A, Pesenti A, Quintel M, Slutsky AS, Ranieri VM; International ECMO Network (ECMONet).

Chest. 2018 Apr;153(4):788-791. doi: 10.1016/j.chest.2017.12.024. Epub 2018 Jan 31. No abstract available.

PMID:
29355550
30.

Acute respiratory distress syndrome.

Laffey JG, Misak C, Kavanagh BP.

BMJ. 2017 Nov 16;359:j5055. doi: 10.1136/bmj.j5055. No abstract available.

PMID:
29146585
31.

Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study.

Laffey JG, Bellani G, Pham T, Fan E, Madotto F, Bajwa EK, Brochard L, Clarkson K, Esteban A, Gattinoni L, van Haren F, Heunks LM, Kurahashi K, Laake JH, Larsson A, McAuley DF, McNamee L, Nin N, Qiu H, Ranieri M, Rubenfeld GD, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group.

Intensive Care Med. 2018 Jan;44(1):157-165. doi: 10.1007/s00134-017-4981-z.

PMID:
29138899
32.

Lessons to learn from epidemiologic studies in ARDS.

McNicholas BA, Rooney GM, Laffey JG.

Curr Opin Crit Care. 2018 Feb;24(1):41-48. doi: 10.1097/MCC.0000000000000473. Review.

PMID:
29135617
33.

Using Activity Trackers to Quantify Postpartum Ambulation: A Prospective Observational Study of Ambulation after Regional Anesthesia and Analgesia Interventions.

Ma J, Martin R, Chan B, Gofeld M, Geary MP, Laffey JG, Abdallah FW.

Anesthesiology. 2018 Mar;128(3):598-608. doi: 10.1097/ALN.0000000000001979.

PMID:
29135475
34.

Suprascapular and Interscalene Nerve Block for Shoulder Surgery: A Systematic Review and Meta-analysis.

Hussain N, Goldar G, Ragina N, Banfield L, Laffey JG, Abdallah FW.

Anesthesiology. 2017 Dec;127(6):998-1013. doi: 10.1097/ALN.0000000000001894. Review.

PMID:
28968280
35.

Stem Cell-based Therapies for Sepsis.

Keane C, Jerkic M, Laffey JG.

Anesthesiology. 2017 Dec;127(6):1017-1034. doi: 10.1097/ALN.0000000000001882. Review.

PMID:
28872482
36.

Noninvasive mechanical ventilation in early acute respiratory distress syndrome.

Grassi A, Foti G, Laffey JG, Bellani G.

Pol Arch Intern Med. 2017 Sep 29;127(9):614-620. doi: 10.20452/pamw.4088. Epub 2017 Aug 17. Review.

37.

The intensive care medicine research agenda for airways, invasive and noninvasive mechanical ventilation.

Jaber S, Bellani G, Blanch L, Demoule A, Esteban A, Gattinoni L, Guérin C, Hill N, Laffey JG, Maggiore SM, Mancebo J, Mayo PH, Mosier JM, Navalesi P, Quintel M, Vincent JL, Marini JJ.

Intensive Care Med. 2017 Sep;43(9):1352-1365. doi: 10.1007/s00134-017-4896-8. Epub 2017 Aug 7. Review.

PMID:
28785882
38.

Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study.

Laffey JG, Madotto F, Bellani G, Pham T, Fan E, Brochard L, Amin P, Arabi Y, Bajwa EK, Bruhn A, Cerny V, Clarkson K, Heunks L, Kurahashi K, Laake JH, Lorente JA, McNamee L, Nin N, Palo JE, Piquilloud L, Qiu H, Jiménez JIS, Esteban A, McAuley DF, van Haren F, Ranieri M, Rubenfeld G, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group.

Lancet Respir Med. 2017 Aug;5(8):627-638. doi: 10.1016/S2213-2600(17)30213-8. Epub 2017 Jun 15.

PMID:
28624388
39.

The authors reply.

Curley GF, Jerkic M, Hogan G, Masterson C, O'Toole D, Devaney J, Laffey JG.

Crit Care Med. 2017 Jul;45(7):e737-e738. doi: 10.1097/CCM.0000000000002480. No abstract available.

PMID:
28622234
40.

Erratum to Protective intraoperative ventilation with higher versus lower levels of positive end-expiratory pressure in obese patients (PROBESE): study protocol for a randomized controlled trial.

Bluth T, Teichmann R, Kiss T, Bobek I, Canet J, Cinnella G, De Baerdemaeker L, Gregoretti C, Hedenstierna G, Hemmes SN, Hiesmayr M, Hollmann MW, Jaber S, Laffey JG, Licker MJ, Markstaller K, Matot I, Müller G, Mills GH, Mulier JP, Putensen C, Rossaint R, Schmitt J, Senturk M, Neto AS, Severgnini P, Sprung J, Vidal Melo MF, Wrigge H, Schultz MJ, Pelosi P, Gama de Abreu M; PROBESE investigators, and the PROtective VEntilation Network (PROVEnet) and on behalf of the Clinical Trial Network of the European Society of Anaesthesiology (ESA).

Trials. 2017 Jun 1;18(1):247. doi: 10.1186/s13063-017-1987-3. No abstract available.

41.

Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial.

Agus A, Hulme C, Verghis RM, McDowell C, Jackson C, O'Kane CM, Laffey JG, McAuley DF.

Crit Care. 2017 May 17;21(1):108. doi: 10.1186/s13054-017-1695-0.

42.

Protective intraoperative ventilation with higher versus lower levels of positive end-expiratory pressure in obese patients (PROBESE): study protocol for a randomized controlled trial.

Bluth T, Teichmann R, Kiss T, Bobek I, Canet J, Cinnella G, De Baerdemaeker L, Gregoretti C, Hedenstierna G, Hemmes SN, Hiesmayr M, Hollmann MW, Jaber S, Laffey JG, Licker MJ, Markstaller K, Matot I, Müller G, Mills GH, Mulier JP, Putensen C, Rossaint R, Schmitt J, Senturk M, Serpa Neto A, Severgnini P, Sprung J, Vidal Melo MF, Wrigge H, Schultz MJ, Pelosi P, Gama de Abreu M; PROBESE investigators; PROtective VEntilation Network (PROVEnet); Clinical Trial Network of the European Society of Anaesthesiology (ESA).

Trials. 2017 Apr 28;18(1):202. doi: 10.1186/s13063-017-1929-0. Erratum in: Trials. 2017 Jun 1;18(1):247.

43.

Fifty Years of Research in ARDS. Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value.

Laffey JG, Matthay MA.

Am J Respir Crit Care Med. 2017 Aug 1;196(3):266-273. doi: 10.1164/rccm.201701-0107CP. Review.

44.
45.

A comparison of videolaryngoscopes for tracheal intubation in predicted difficult airway: a feasibility study.

Vargas M, Pastore A, Aloj F, Laffey JG, Servillo G.

BMC Anesthesiol. 2017 Feb 20;17(1):25. doi: 10.1186/s12871-017-0318-2.

46.

Some remaining important questions after LUNG SAFE : Discussion of "Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study".

Dreyfuss D, Gaudry S, Madotto F, Laffey JG.

Intensive Care Med. 2017 Apr;43(4):598-599. doi: 10.1007/s00134-017-4706-3. Epub 2017 Feb 17. No abstract available.

PMID:
28213623
47.

Fifty Years of Research in ARDS. Insight into Acute Respiratory Distress Syndrome. From Models to Patients.

Laffey JG, Kavanagh BP.

Am J Respir Crit Care Med. 2017 Jul 1;196(1):18-28. doi: 10.1164/rccm.201612-2415CI. Review.

PMID:
28146637
48.

Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.

Nagendran M, McAuley DF, Kruger PS, Papazian L, Truwit JD, Laffey JG, Thompson BT, Clarke M, Gordon AC.

Intensive Care Med. 2017 May;43(5):663-671. doi: 10.1007/s00134-016-4649-0. Epub 2016 Dec 21. Review.

49.

Continued under-recognition of acute respiratory distress syndrome after the Berlin definition: what is the solution?

Laffey JG, Pham T, Bellani G.

Curr Opin Crit Care. 2017 Feb;23(1):10-17. doi: 10.1097/MCC.0000000000000381. Review.

PMID:
27922845
50.

Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.

McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, Dupont LJ, Fardon TC, Wilson R, Loebinger MR, Skrbic D, Obradovic D, De Soyza A, Ward C, Laffey JG, Rutherford RM, Chalmers JD.

Lancet Respir Med. 2016 Dec;4(12):969-979. doi: 10.1016/S2213-2600(16)30320-4. Epub 2016 Nov 16.

Supplemental Content

Loading ...
Support Center